Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05227534
NA

Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)

Sponsor: Guangzhou Burning Rock Dx Co., Ltd.

View on ClinicalTrials.gov

Summary

PREVENT is a prospective, multicenter, interventional study evaluating the performance of the OverC multi-cancer detection blood test in asymptomatic individuals with cancer risk.

Official title: A Prospective Multi-canceR Early-detection and interVENTional Study in Asymptomatic Individuals: PREVENT

Key Details

Gender

All

Age Range

40 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

12500

Start Date

2022-06-01

Completion Date

2028-12-31

Last Updated

2022-07-06

Healthy Volunteers

Yes

Interventions

DEVICE

OverC multi-cancer detection blood test

Blood collection for the OverC multi-cancer detection blood test and standard-of-care screening with return of results

Locations (1)

West China Hospital, Sichuan University

Chengdu, Sichuan, China